Food Informatics—Review of the Current State-of-the-Art, Revised Definition, and Classification into the Research Landscape

por Krupitzer, Christian, Stein, Anthony
Publicado 2021

Role of Radiation Based Conditioning Regimens in Patients With High-Risk AML Undergoing Allogenic Transplantation in Remission or Active Disease and Mechanisms of Post-Transplant R...

por Salhotra, Amandeep, Stein, Anthony Selwyn
Publicado 2022

Venetoclax-containing regimens in acute myeloid leukemia

por Aldoss, Ibrahim, Pullarkat, Vinod, Stein, Anthony S.
Publicado 2021

Immune Biology of Acute Myeloid Leukemia: Implications for Immunotherapy

por Khaldoyanidi, Sophia, Nagorsen, Dirk, Stein, Anthony, Ossenkoppele, Gerrit, Subklewe, Marion
Publicado 2021

Neurologic adverse events in patients with relapsed/refractory acute lymphoblastic leukemia treated with blinatumomab: management and mitigating factors

por Stein, Anthony S., Schiller, Gary, Benjamin, Ramsis, Jia, Catherine, Zhang, Alicia, Zhu, Min, Zimmerman, Zachary, Topp, Max S.
Publicado 2018

First pediatric experience of SL-401, a CD123-targeted therapy, in patients with blastic plasmacytoid dendritic cell neoplasm: report of three cases

por Sun, Weili, Liu, Huaying, Kim, Young, Karras, Nicole, Pawlowska, Anna, Toomey, Debbie, Kyono, Wade, Gaynon, Paul, Rosenthal, Joseph, Stein, Anthony
Publicado 2018

Blinatumomab as first salvage versus second or later salvage in adults with relapsed/refractory B‐cell precursor acute lymphoblastic leukemia: Results of a pooled analysis

por Topp, Max S., Stein, Anthony S., Gökbuget, Nicola, Horst, Heinz‐August, Boissel, Nicolas, Martinelli, Giovanni, Kantarjian, Hagop, Brüggemann, Monika, Chen, Yuqi, Zugmaier, Gerhard
Publicado 2021

Benefit–Risk Assessment of Blinatumomab in the Treatment of Relapsed/Refractory B-Cell Precursor Acute Lymphoblastic Leukemia

por Stein, Anthony, Franklin, Janet L., Chia, Victoria M., Arrindell, Deborah, Kormany, William, Wright, Jacqueline, Parson, Mandy, Amouzadeh, Hamid R., Choudhry, Jessica, Joseph, Guiandre
Publicado 2018

Long-term follow up of patients with hematological malignancies treated with total body irradiation using intensity modulated radiation therapy

por Ladbury, Colton, Hao, Claire, Yang, Dongyun, Hui, Susanta, Han, Chunhui, Liu, An, Salhotra, Amandeep, Nakamura, Ryotaro, Rosenthal, Joseph, Stein, Anthony, Wong, Jeffrey, Dandapani, Savita
Publicado 2022

Blinatumomab compared with standard of care for the treatment of adult patients with relapsed/refractory Philadelphia chromosome–positive B‐precursor acute lymphoblastic leukemia...

por Rambaldi, Alessandro, Ribera, Josep‐Maria, Kantarjian, Hagop M., Dombret, Hervé, Ottmann, Oliver G., Stein, Anthony S., Tuglus, Catherine A., Zhao, Xiaoyue, Kim, Christopher, Martinelli, Giovanni
Publicado 2019

Long‐term survival of patients with relapsed/refractory acute lymphoblastic leukemia treated with blinatumomab

por Topp, Max S., Gökbuget, Nicola, Zugmaier, Gerhard, Stein, Anthony S., Dombret, Hervé, Chen, Yuqi, Ribera, Josep‐Maria, Bargou, Ralf C., Horst, Heinz‐August, Kantarjian, Hagop M.
Publicado 2020

Exosome-driven lipolysis and bone marrow niche remodeling support leukemia expansion

por Kumar, Bijender, Orellana, Marvin, Brooks, Jamison, Madabushi, Srideshikan Sargur, Vishwasrao, Paresh, Parra, Liliana E., Sanchez, James, Salhotra, Amandeep, Stein, Anthony, Chen, Ching-Cheng, Marcucci, Guido, Hui, Susanta Kumar
Publicado 2020

Total marrow irradiation (TMI): Addressing an unmet need in hematopoietic cell transplantation - a single institution experience review

por Wong, Jeffrey Y.C., Liu, An, Han, Chunhui, Dandapani, Savita, Schultheiss, Timothy, Palmer, Joycelynne, Yang, Dongyun, Somlo, George, Salhotra, Amandeep, Hui, Susanta, Al Malki, Monzr M., Rosenthal, Joseph, Stein, Anthony
Publicado 2022

Long-Term Benefits of Tagraxofusp for Patients With Blastic Plasmacytoid Dendritic Cell Neoplasm

por Pemmaraju, Naveen, Sweet, Kendra L., Stein, Anthony S., Wang, Eunice S., Rizzieri, David A., Vasu, Sumithira, Rosenblat, Todd L., Brooks, Christopher L., Habboubi, Nassir, Mughal, Tariq I., Kantarjian, Hagop, Konopleva, Marina, Lane, Andrew A.
Publicado 2022

A Phase 1 Trial Dose Escalation Study of Tipifarnib on a Week-On, Week-Off Schedule in Relapsed, Refractory or High-Risk Myeloid Leukemia

por Kirschbaum, Mark, Synold, Timothy, Stein, Anthony S., Tuscano, Joseph, Zain, Jasmine M., Popplewell, Leslie, Karanes, Chatchada, O'Donnell, Margaret R., Pulone, Bernadette, Rincon, Amalia, Wright, John, Frankel, Paul, Forman, Stephen J., Newman, Edward M.
Publicado 2011

Conditional Survival and Cause-specific Mortality after Autologous Hematopoietic Cell Transplantation for Hematological Malignancies

por VanderWalde, Ari M., Sun, Can-Lan, Laddaran, Lester, Francisco, Liton, Armenian, Saro, Berano-Teh, Jennifer, Wong, F. Lennie, Popplewell, Leslie, Somlo, George, Stein, Anthony S., Nademanee, Auayporn, Krishnan, Amrita, Kogut, Neil, Forman, Stephen, Bhatia, Smita
Publicado 2012

Role of radiotherapy in treatment of extramedullary relapse following total marrow and lymphoid irradiation in high-risk and/or relapsed/refractory acute leukemia

por Ladbury, Colton, Semwal, Hemal, Hong, Daniel, Yang, Dongyun, Hao, Claire, Han, Chunhui, Liu, An, Marcucci, Guido, Rosenthal, Joseph, Hui, Susanta, Salhotra, Amandeep, Ali, Haris, Nakamura, Ryotaro, Stein, Anthony, Al Malki, Monzr, Wong, Jeffrey Y. C., Dandapani, Savita
Publicado 2022

Phase-2 Trial of an Intensified Conditioning Regimen for Allogeneic Hematopoietic Cell Transplant for Poor-Risk Leukemia

por Stein, Anthony S., O’Donnell, Margaret R., Synold, Timothy W., Dagis, Andrew C., Tsirunyan, Anjela, Nademanee, Auayporn P., Parker, Pablo M., Pullarkat, Vinod A., Snyder, David S., Spielberger, Ricardo T., Wong, Jeffrey Y.C., Alvarnas, Joseph C., Thomas, Sandra H., Forman, Stephen J.
Publicado 2010

Tacrolimus initial steady state level in post-transplant cyclophosphamide based GvHD prophylaxis regimens

por Yao, Janny M., Yang, Dongyun, Clark, Mary C., Otoukesh, Salman, Cao, Thai, Ali, Haris, Arslan, Shukaib, Aldoss, Ibrahim, Artz, Andrew, Amanam, Idoroenyi, Salhotra, Amandeep, Pullarkat, Vinod, Sandhu, Karamjeet, Stein, Anthony, Marcucci, Guido, Forman, Stephen J., Nakamura, Ryotaro, Al Malki, Monzr M.
Publicado 2022

P724: UPDATED SUBSTUDY RESULTS FOR IVOSIDENIB IN IDH1-MUTANT RELAPSED/REFRACTORY MYELODYSPLASTIC SYNDROME

por Dinardo, Courtney, Roboz, Gail, M. Watts, Justin, Madanat, Yazan, T Prince, Gabrielle, Baratam, Praneeth, de Botton, Stéphane, Stein, Anthony, M Foran, James, L Arellano, Martha, Sallman, David, M Marchione, Dylan, Bai, Xiaofei, A Patel, Prapti, M Kapsalis, Stephanie, Garcia-Manero, Guillermo, Fathi, Amir
Publicado 2023